Provided by Tiger Fintech (Singapore) Pte. Ltd.

HeartSciences Inc

3.20
-0.0314-0.97%
Post-market: 3.500.3014+9.42%16:27 EDT
Volume:62.67K
Turnover:209.95K
Market Cap:3.46M
PE:-0.31
High:3.54
Open:3.42
Low:3.18
Close:3.23
Loading ...

Company Profile

Company Name:
HeartSciences Inc
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
15
Office Location:
550 Reserve Street,Suite 360,Southlake,Texas,United States
Zip Code:
76092
Fax:
- -
Introduction:
Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Directors

Name
Position
Andrew Simpson
President, Chief Executive Officer and Chairman of the Board
Brian Szymczak
Independent Director
Bruce Bent
Independent Director
David R. Wells
Independent Director
Mark Hilz
Chief Operating Officer, Secretary and Director

Shareholders

Name
Position
Andrew Simpson
President, Chief Executive Officer and Chairman of the Board
Mark Hilz
Chief Operating Officer, Secretary and Director
Danielle Watson
Chief Financial Officer and Treasurer